Author/Authors :
Besharati ، Shahin Zanjan Metabolic Diseases Research Center - Zanjan University of Medical Sciences , Abbaspourrad ، Zahra Zanjan Metabolic Diseases Research Center - Zanjan University of Medical Sciences , Chiti ، Hossein Metabolic Diseases Research Center - Zanjan University of Medical Sciences , Parsamanesh ، Negin Metabolic Diseases Research Center - Zanjan University of Medical Sciences
Abstract :
The 2019 global Coronavirus syndrome pandemic (COVID-19) has entered more than two hundred countries around the world, involving 82 million persons and 1,800,000 deaths (until January, 1st 2021). We report on COVID-19 infection in the context of a Cushing s syndrome (CS) from Iran. A 36-year-old man with proximal myopathy, plethora, and striae with central obesity was evaluated for Cushing s syndrome. During the high dose dexamethasone test, the patient developed symptoms of cough, low-grade fever, and weakness then was admitted to the ICU with a diagnosis of COVID-19. Despite treatment according to national protocols for COVID-19, the patient unfortunately died. In this report, we intend to discuss the various aspects of Cushing s syndrome and severe COVID-19 infection.
Keywords :
Coronavirus disease (COVID , 19) , Cushing s syndrome , Immunosuppression
